Is There a Need to Reformulate Attention Deficit Hyperactivity Disorder Criteria in Future Nosologic Classifications?
The development of classification systems in psychiatry has been a complex task. In clinical settings, these classification systems help communication about disorders among professionals and between them and their patients. In addition, a diagnosis based on these nosologic systems has a central role for mental health insurance policies. There is a recent interest in research opportunities for improving the nosology of attention deficit hyperactivity disorder (ADHD) in future classification systems like the DSM-V and the ICD-11. This article addresses the potential need to reformulate ADHD criteria in future nosologic classifications.
ADHD Outpatient Program, Division of Child and Adolescent Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Rua Ramiro Barcelos 2350, Room 2201A, Porto Alegre, RS, 90035-003 Brazil
Potential conflict of interest: The ADHD Outpatient Program receives research support from the following pharmaceutical companies: Bristol-Myers Squibb, Eli-Lilly and Company, Janssen-Cilag, and Novartis. Professor Rohde is on the speakers' bureau or is a consultant for the same companies and is on the advisory board for Eli Lilly and Company.
Funding sources: This work was partially supported by research grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) (Grant MCT/CNPq 02/2006 - Universal), Hospital de Clinicas de Porto Alegre.
A previous version of this manuscript was presented in the Eunethydis meeting (ADHD European Consortium), October 2006, Bruges, Belgium. The opinions expressed here reflect solely the personal view of the author.
ABSTRACT